Pharmaceutical composition for treating and/or preventing cancer
According to the present invention, a cancer antigen protein to be specifically expressed on the surfaces of cancer cells is identified and thus the use of an antibody targeting the cancer antigen protein as an agent for treating and/or preventing cancer is provided. Specifically, the present invention provides a pharmaceutical composition for treating and/or preventing a cancer, which comprises an antibody or a fragment thereof as an active ingredient having immunological reactivity with a partial polypeptide of CAPRIN-1, which is represented by any of even-numbered sequences of SEQ ID NOS: 2 to 30, wherein the polypeptide has the amino acid sequence represented by SEQ ID NO: 37 or an amino acid sequence having 80% or more sequence identity with the amino acid sequence represented by SEQ ID NO: 37.
1. A method for treating and/or preventing recurrence of a CAPRIN-1 expressing cancer, comprising administering to a subject an antibody or a fragment thereof having immunological reactivity with a polypeptide that consists of the amino acid sequence of SEQ ID NO: 37.
2. A method for treating and/or preventing recurrence of a CAPRIN-1 expressing cancer, comprising administering to a subject a pharmaceutical combination comprising an antitumor agent, and
an antibody or a fragment thereof as an active ingredient that has immunological reactivity with a partial polypeptide of CAPRIN-1, wherein CAPRIN-1 is any of the even-numbered sequences of SEQ ID NOS: 2 to 30, and wherein the partial polypeptide consists of the amino acid sequence of SEQ ID NO: 37, or
an antibody or a fragment thereof having immunological reactivity with a polypeptide that consists of the amino acid sequence of SEQ ID NO: 37.
3. A method for treating and/or preventing recurrence of a CAPRIN-1 expressing cancer, comprising
administering to a subject an antibody or a fragment thereof as an active ingredient that has immunological reactivity with a partial polypeptide of CAPRIN-1,
wherein CAPRIN-1 is any of the even-numbered sequences of SEQ ID NOS: 2 to 30, and
wherein the partial polypeptide of CAPRIN-1 consists of the amino acid sequence of SEQ ID NO: 37.
4. The method of claim 1 , wherein the cancer is breast cancer, brain tumor, leukemia, lymphoma, lung cancer, mastocytoma, renal cancer, uterine cervix cancer, bladder cancer, esophageal cancer, gastric cancer, or colorectal cancer.
5. The method of claim 1 , wherein the antibody is a monoclonal antibody or a polyclonal antibody.
6. The method of claim 1 , wherein the antibody is a human antibody, humanized antibody, chimeric antibody, single chain antibody, or bispecific antibody.
7. The method of claim 2 , wherein the cancer is breast cancer, brain tumor, leukemia, lymphoma, lung cancer, mastocytoma, renal cancer, uterine cervix cancer, bladder cancer, esophageal cancer, gastric cancer, or colorectal cancer.
8. The method of claim 2 , wherein the antibody is a monoclonal antibody or a polyclonal antibody.
9. The method of claim 2 , wherein the antibody is a human antibody, humanized antibody, chimeric antibody, single chain antibody, or bispecific antibody.
10. The method of claim 2 , wherein the antibody or a fragment thereof has a cytotoxic activity against a cancer cell expressing a CAPRIN-1 protein.
11. The method of claim 3 , wherein the cancer is breast cancer, brain tumor, leukemia, lymphoma, lung cancer, mastocytoma, renal cancer, uterine cervix cancer, bladder cancer, esophageal cancer, gastric cancer, or colorectal cancer.
12. The method of claim 3 , wherein the antibody is a monoclonal antibody or a polyclonal antibody.
13. The method of claim 3 , wherein the antibody is a human antibody, humanized antibody, chimeric antibody, single chain antibody, or bispecific antibody.